{"id":"https://openalex.org/W2755428328","doi":"https://doi.org/10.1016/j.ijpharm.2017.09.031","title":"Development of an abiraterone acetate formulation with improved oral bioavailability guided by absorption modeling based on in vitro dissolution and permeability measurements","display_name":"Development of an abiraterone acetate formulation with improved oral bioavailability guided by absorption modeling based on in vitro dissolution and permeability measurements","publication_year":2017,"publication_date":"2017-09-16","ids":{"openalex":"https://openalex.org/W2755428328","doi":"https://doi.org/10.1016/j.ijpharm.2017.09.031","mag":"2755428328","pmid":"https://pubmed.ncbi.nlm.nih.gov/28919099"},"language":"en","primary_location":{"id":"doi:10.1016/j.ijpharm.2017.09.031","doi":"https://doi.org/10.1016/j.ijpharm.2017.09.031","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.ijpharm.2017.09.031","pdf_url":null,"source":{"id":"https://openalex.org/S131016564","display_name":"International Journal of Pharmaceutics","issn_l":"0378-5173","issn":["0378-5173","1873-3476"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Pharmaceutics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5022023583","display_name":"Tam\u00e1s Solymosi","orcid":"https://orcid.org/0000-0003-2973-9696","observed_orcids":["https://orcid.org/0000-0003-2973-9696"]},"institutions":[{"id":"https://openalex.org/I4210136262","display_name":"N-Gene (Hungary)","ror":"https://ror.org/0397v4g85","country_code":"HU","type":"company","lineage":["https://openalex.org/I4210136262","https://openalex.org/I4210148168"]}],"countries":["HU"],"is_corresponding":false,"raw_author_name":"Tam\u00e1s Solymosi","raw_affiliation_strings":["NanGenex Inc., 47-49 Madar\u00e1sz Viktor u., Budapest, H-1138, Hungary"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NanGenex Inc., 47-49 Madar\u00e1sz Viktor u., Budapest, H-1138, Hungary","institution_ids":["https://openalex.org/I4210136262"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009107739","display_name":"Zsolt \u00d6tv\u00f6s","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210136262","display_name":"N-Gene (Hungary)","ror":"https://ror.org/0397v4g85","country_code":"HU","type":"company","lineage":["https://openalex.org/I4210136262","https://openalex.org/I4210148168"]}],"countries":["HU"],"is_corresponding":false,"raw_author_name":"Zsolt \u00d6tv\u00f6s","raw_affiliation_strings":["NanGenex Inc., 47-49 Madar\u00e1sz Viktor u., Budapest, H-1138, Hungary"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NanGenex Inc., 47-49 Madar\u00e1sz Viktor u., Budapest, H-1138, Hungary","institution_ids":["https://openalex.org/I4210136262"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019148445","display_name":"R\u00e9ka Angi","orcid":"https://orcid.org/0009-0001-8647-4615","observed_orcids":["https://orcid.org/0009-0001-8647-4615"]},"institutions":[{"id":"https://openalex.org/I4210136262","display_name":"N-Gene (Hungary)","ror":"https://ror.org/0397v4g85","country_code":"HU","type":"company","lineage":["https://openalex.org/I4210136262","https://openalex.org/I4210148168"]}],"countries":["HU"],"is_corresponding":false,"raw_author_name":"R\u00e9ka Angi","raw_affiliation_strings":["NanGenex Inc., 47-49 Madar\u00e1sz Viktor u., Budapest, H-1138, Hungary"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NanGenex Inc., 47-49 Madar\u00e1sz Viktor u., Budapest, H-1138, Hungary","institution_ids":["https://openalex.org/I4210136262"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021577596","display_name":"Betti Ordasi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210136262","display_name":"N-Gene (Hungary)","ror":"https://ror.org/0397v4g85","country_code":"HU","type":"company","lineage":["https://openalex.org/I4210136262","https://openalex.org/I4210148168"]}],"countries":["HU"],"is_corresponding":false,"raw_author_name":"Betti Ordasi","raw_affiliation_strings":["NanGenex Inc., 47-49 Madar\u00e1sz Viktor u., Budapest, H-1138, Hungary"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NanGenex Inc., 47-49 Madar\u00e1sz Viktor u., Budapest, H-1138, Hungary","institution_ids":["https://openalex.org/I4210136262"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083624386","display_name":"Tam\u00e1s Jord\u00e1n","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210136262","display_name":"N-Gene (Hungary)","ror":"https://ror.org/0397v4g85","country_code":"HU","type":"company","lineage":["https://openalex.org/I4210136262","https://openalex.org/I4210148168"]}],"countries":["HU"],"is_corresponding":false,"raw_author_name":"Tam\u00e1s Jord\u00e1n","raw_affiliation_strings":["NanGenex Inc., 47-49 Madar\u00e1sz Viktor u., Budapest, H-1138, Hungary"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NanGenex Inc., 47-49 Madar\u00e1sz Viktor u., Budapest, H-1138, Hungary","institution_ids":["https://openalex.org/I4210136262"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075795408","display_name":"S\u00e1ndor Semsey","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210136262","display_name":"N-Gene (Hungary)","ror":"https://ror.org/0397v4g85","country_code":"HU","type":"company","lineage":["https://openalex.org/I4210136262","https://openalex.org/I4210148168"]}],"countries":["HU"],"is_corresponding":false,"raw_author_name":"S\u00e1ndor Semsey","raw_affiliation_strings":["NanGenex Inc., 47-49 Madar\u00e1sz Viktor u., Budapest, H-1138, Hungary"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NanGenex Inc., 47-49 Madar\u00e1sz Viktor u., Budapest, H-1138, Hungary","institution_ids":["https://openalex.org/I4210136262"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071142475","display_name":"L\u00e1szl\u00f3 Mil\u00e1n Moln\u00e1r","orcid":"https://orcid.org/0000-0003-4535-7292","observed_orcids":["https://orcid.org/0000-0003-4535-7292"]},"institutions":[{"id":"https://openalex.org/I4210136262","display_name":"N-Gene (Hungary)","ror":"https://ror.org/0397v4g85","country_code":"HU","type":"company","lineage":["https://openalex.org/I4210136262","https://openalex.org/I4210148168"]}],"countries":["HU"],"is_corresponding":false,"raw_author_name":"L\u00e1szl\u00f3 Moln\u00e1r","raw_affiliation_strings":["NanGenex Inc., 47-49 Madar\u00e1sz Viktor u., Budapest, H-1138, Hungary"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NanGenex Inc., 47-49 Madar\u00e1sz Viktor u., Budapest, H-1138, Hungary","institution_ids":["https://openalex.org/I4210136262"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038054744","display_name":"Soma R\u00e1nky","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210136262","display_name":"N-Gene (Hungary)","ror":"https://ror.org/0397v4g85","country_code":"HU","type":"company","lineage":["https://openalex.org/I4210136262","https://openalex.org/I4210148168"]}],"countries":["HU"],"is_corresponding":false,"raw_author_name":"Soma R\u00e1nky","raw_affiliation_strings":["NanGenex Inc., 47-49 Madar\u00e1sz Viktor u., Budapest, H-1138, Hungary"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NanGenex Inc., 47-49 Madar\u00e1sz Viktor u., Budapest, H-1138, Hungary","institution_ids":["https://openalex.org/I4210136262"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084790763","display_name":"Genov\u00e9va Filipcsei","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210136262","display_name":"N-Gene (Hungary)","ror":"https://ror.org/0397v4g85","country_code":"HU","type":"company","lineage":["https://openalex.org/I4210136262","https://openalex.org/I4210148168"]}],"countries":["HU"],"is_corresponding":false,"raw_author_name":"Genov\u00e9va Filipcsei","raw_affiliation_strings":["NanGenex Inc., 47-49 Madar\u00e1sz Viktor u., Budapest, H-1138, Hungary"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NanGenex Inc., 47-49 Madar\u00e1sz Viktor u., Budapest, H-1138, Hungary","institution_ids":["https://openalex.org/I4210136262"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073656213","display_name":"G\u00e1bor Heltovics","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G\u00e1bor Heltovics","raw_affiliation_strings":["Druggability Technologies Holdings Ltd. Tower Business Centre, Tower Street, Swatar BKR 4013, Malta"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Druggability Technologies Holdings Ltd. Tower Business Centre, Tower Street, Swatar BKR 4013, Malta","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5013293839","display_name":"Hristos Glavinas","orcid":"https://orcid.org/0000-0003-4785-2713","observed_orcids":["https://orcid.org/0000-0003-4785-2713"]},"institutions":[{"id":"https://openalex.org/I4210136262","display_name":"N-Gene (Hungary)","ror":"https://ror.org/0397v4g85","country_code":"HU","type":"company","lineage":["https://openalex.org/I4210136262","https://openalex.org/I4210148168"]}],"countries":["HU"],"is_corresponding":true,"raw_author_name":"Hristos Glavinas","raw_affiliation_strings":["NanGenex Inc., 47-49 Madar\u00e1sz Viktor u., Budapest, H-1138, Hungary. Electronic address: hristos.glavinas@nangenex.com","NanGenex Inc., 47-49 Madar\u00e1sz Viktor u., Budapest, H-1138, Hungary"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NanGenex Inc., 47-49 Madar\u00e1sz Viktor u., Budapest, H-1138, Hungary. Electronic address: hristos.glavinas@nangenex.com","institution_ids":["https://openalex.org/I4210136262"]},{"raw_affiliation_string":"NanGenex Inc., 47-49 Madar\u00e1sz Viktor u., Budapest, H-1138, Hungary","institution_ids":["https://openalex.org/I4210136262"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5013293839"],"corresponding_institution_ids":["https://openalex.org/I4210136262"],"apc_list":{"value":4650,"currency":"USD","value_usd":4650},"apc_paid":null,"fwci":1.6661,"has_fulltext":false,"cited_by_count":32,"citation_normalized_percentile":{"value":0.78942498,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"532","issue":"1","first_page":"427","last_page":"434"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11881","display_name":"Crystallization and Solubility Studies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2505","display_name":"Materials Chemistry"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/abiraterone-acetate","display_name":"abiraterone","score":1.0},{"id":"https://openalex.org/keywords/oral-bioavailability","display_name":"oral bioavailability","score":0.9850000143051147},{"id":"https://openalex.org/keywords/poorly-water-soluble-drugs","display_name":"poorly water-soluble drugs","score":0.8650000095367432},{"id":"https://openalex.org/keywords/absorption-modeling","display_name":"absorption modeling","score":0.6320000290870667},{"id":"https://openalex.org/keywords/particle-size-reduction","display_name":"particle size reduction","score":0.8529999852180481},{"id":"https://openalex.org/keywords/surfactants","display_name":"surfactants","score":0.7480000257492065},{"id":"https://openalex.org/keywords/dissolution-rate","display_name":"dissolution rate","score":0.7080000042915344},{"id":"https://openalex.org/keywords/drug-solubility","display_name":"drug solubility","score":0.8019999861717224},{"id":"https://openalex.org/keywords/intestinal-permeability","display_name":"intestinal permeability","score":0.9399999976158142},{"id":"https://openalex.org/keywords/food-effect","display_name":"food effect","score":0.906000018119812},{"id":"https://openalex.org/keywords/beagle","display_name":"beagle dogs","score":0.5389999747276306}],"concepts":[{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.9556101560592651},{"id":"https://openalex.org/C2775832370","wikidata":"https://www.wikidata.org/wiki/Q27888393","display_name":"Abiraterone acetate","level":5,"score":0.7972209453582764},{"id":"https://openalex.org/C155574463","wikidata":"https://www.wikidata.org/wiki/Q170731","display_name":"Solubility","level":2,"score":0.7058582901954651},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6753486394882202},{"id":"https://openalex.org/C88380143","wikidata":"https://www.wikidata.org/wiki/Q416674","display_name":"Dissolution","level":2,"score":0.6600549221038818},{"id":"https://openalex.org/C125287762","wikidata":"https://www.wikidata.org/wiki/Q1758948","display_name":"Absorption (acoustics)","level":2,"score":0.5583996772766113},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.5151039958000183},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.4914349317550659},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3768472969532013},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.2595676779747009},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.12893393635749817},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.07788529992103577},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.0},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.0},{"id":"https://openalex.org/C159985019","wikidata":"https://www.wikidata.org/wiki/Q181790","display_name":"Composite material","level":1,"score":0.0},{"id":"https://openalex.org/C2777899217","wikidata":"https://www.wikidata.org/wiki/Q4759439","display_name":"Androgen deprivation therapy","level":4,"score":0.0},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000069501","descriptor_name":"Abiraterone Acetate","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001682","descriptor_name":"Biological Availability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002626","descriptor_name":"Chemistry, Pharmaceutical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004285","descriptor_name":"Dogs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010539","descriptor_name":"Permeability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012995","descriptor_name":"Solubility","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.ijpharm.2017.09.031","doi":"https://doi.org/10.1016/j.ijpharm.2017.09.031","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.ijpharm.2017.09.031","pdf_url":null,"source":{"id":"https://openalex.org/S131016564","display_name":"International Journal of Pharmaceutics","issn_l":"0378-5173","issn":["0378-5173","1873-3476"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Pharmaceutics","raw_type":"journal-article"},{"id":"pmid:28919099","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28919099","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of pharmaceutics","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.8371999859809875,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":23,"referenced_works":["https://openalex.org/W237620800","https://openalex.org/W1498305210","https://openalex.org/W1517661852","https://openalex.org/W1578055482","https://openalex.org/W1603855465","https://openalex.org/W1977698867","https://openalex.org/W1979167538","https://openalex.org/W2001471381","https://openalex.org/W2015014216","https://openalex.org/W2018220913","https://openalex.org/W2036753807","https://openalex.org/W2056211275","https://openalex.org/W2077781847","https://openalex.org/W2078693635","https://openalex.org/W2103407911","https://openalex.org/W2155327077","https://openalex.org/W2170544517","https://openalex.org/W2314472960","https://openalex.org/W2598617552","https://openalex.org/W2607068605","https://openalex.org/W2742217960","https://openalex.org/W4251505294","https://openalex.org/W6815670826"],"related_works":["https://openalex.org/W3016615398","https://openalex.org/W4281677721","https://openalex.org/W4404839953","https://openalex.org/W4384662618","https://openalex.org/W3214819351","https://openalex.org/W2768693657","https://openalex.org/W4390776103","https://openalex.org/W4206789727","https://openalex.org/W3001519615","https://openalex.org/W3088497219"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":8},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2017-09-25T00:00:00"}